Criteria for Financial Assistance:  

In order to ease some of the financial burdens of ongoing treatment, LEF provides financial assistance to families of children diagnosed with cancer.

Criteria to be met:

  • Child must be diagnosed with cancer
  • Child’s original diagnosis must be before age 18, and the child must currently be under age 21
  • Patient must be in active oncology treatment and one of the following:
    1. Experiencing a pediatric oncology relapse.
    2. Enrolling in or currently enrolled in a clinical trial for active oncology treatment intervention.
  • Families are eligible for up to $1000.00 in financial assistance per calendar year (January – December).
  • At this time, assistance is only available for families in Northeastern, PA and Toledo, OH.
  • We respond to all requests within 1-2 business days.
  • Approved applicants will receive a check payable to the parent.

 

Verification:

  • LEF requires a referral from the child’s medical team to verify diagnosis. These can be submitted to info@littleericsfoundation.org.
  • The application must be signed by the child's social worker or doctor.
  • Applications will be reviewed and approved by the Little Eric’s Foundation board of directors.

 

 

Charitable Recipients:


  • 2015-2019:  $16,000 was donated to local children over the past 5 years in the midst of fighting cancer. This money is used to help defray the costs of travel and medical expenses while undergoing treatments. 

 

  • March 10, 2019: $40,475 was donated to Memorial Sloan Kettering Cancer Center for pediatric cancer research.

 

  • March 11, 2018: $40,075 was donated to Memorial Sloan Kettering Cancer Center for pediatric cancer research.

 

  • March 12, 2017:  $25,330 was donated to Dr. Miho Hatano Pediatric Hematologist/Oncologist, New York Presbyterian/Weill Cornell and Dr. David Lyden , Pediatric Neuro-Oncologist, Memorial Sloan Kettering Cancer Center.  Their goal is to determine a first step toward a better characterization of Ependymoma-derived exosomes to develop a reliably measurable biomarker to follow treatment responses and to detect early recurrences in a noninvasive way. They are also aiming to identify potential exosomal proteins that can serve as a drug for treating Ependymoma. 

 

  • March 13, 2016:  $25,750 was given to Dr. Ratna Behal, Pediatric Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center to assist with her ongoing research involving primary pediatric malignant brain tumors that are commonly refractory to conventional therapy.  Her overall goal is to improve the quality of life for pediatric patients. 

 

  • March 8, 2015:  $18,000 was given to Memorial Sloan Kettering Cancer Center, where 100% of our donation will be going toward cancer research. Eric was treated at this hospital and we hold the staff and their efforts very close to our hearts.